Primary Site >> Pancreatic Cancer
Gene >> PYY
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells. PMID: 2080016 |
Ref: Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels. PMID: 7638738 Ref: Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. PMID: 7791350 |
Ref: Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth. PMID: 8554139 |
Ref: Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth. PMID: 10644462 |
Ref: Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells. PMID: 11331476 |
Ref: Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor. PMID: 12069504 |
Ref: PYY and the pancreas: inhibition of tumor growth and inflammation. PMID: 17194501 |
Ref: [Surgical treatment [corrected] of type 2 diabetes. Neuroendocrine basis in relation to three operated cases in Rebagliati Hospital]. PMID: 18641782 |
Ref: Peptide YY mediates inhibition of tumor growth and inflammation. PMID: 19347290 |
Ref: Peptide tyrosine-tyrosine combined with its receptors exhibits an anti-cancer potential in pancreatic cancer MiaPaCa-2 cell. PMID: 25533827 |
Ref: Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss. PMID: 28027898 |